From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial

Author(s):: Cock, L. de; Draulans, C.; Pos, F.J.; Isebaert, S.; Roover, R. de; Heide, U.A. van der; Smeenk, R.J.; Kunze-Busch, M.; Zyp, J.V. van; Boer, H. de; Kerkmeijer, L.G.W.; Haustermans, K.

Prostate cancerStereotactic body RadiotherapyFocal boostUltra-hypofractionationOverall treatment time

Date issued: 2023-06-14
Language: English
Publisher: Elsevier
Is part of: Radiotherapy & Oncology
hdl: 1887/3759978
doi: 10.1016/j.radonc.2023.109713
URL: https://www.sciencedirect.com/science/article/pii/S0167814023002517?via%3Dihub